{"id":52587,"date":"2023-01-05T16:03:06","date_gmt":"2023-01-05T15:03:06","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/"},"modified":"2023-01-05T16:03:06","modified_gmt":"2023-01-05T15:03:06","slug":"nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/","title":{"rendered":"Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech"},"content":{"rendered":"
\n

MADISON, Wis.–(BUSINESS WIRE)–Nimble Therapeutics, a biotechnology company leveraging its next-generation peptide discovery platform to identify medicines for challenging-to-drug targets, today announced that the company has expanded its collaboration and executed a license agreement with Genentech, a member of the Roche Group (SIX:RO, ROG; OTCQX: RHHBY), for the discovery of peptide therapies for the treatment of diseases across multiple therapeutic areas.\n<\/p>\n

<\/a><\/p>\n

\n\u201cWe are excited to significantly expand our partnership and strengthen our collaboration with Genentech,\u201d said Jigar Patel, Founder & CEO of Nimble Therapeutics. \u201cGenentech has been a valuable strategic partner and we are proud that our success thus far has led to the opportunity to significantly broaden our work together with both Genentech and Roche.\u201d\n<\/p>\n

\nUnder the terms of the agreement, Nimble will receive a $20 million upfront payment; near-term, preclinical, clinical, and commercial milestone payments that could exceed $1.1 billion; as well as tiered royalties. Nimble will apply its platform against multiple targets, and Genentech and Roche will be responsible for preclinical and clinical development, and commercialization of any resulting products.\n<\/p>\n

\n\u201cThis expanded partnership with Genentech, and the multiple recently achieved milestones across all our partnered programs, demonstrates Nimble\u2019s capability to deliver peptide therapeutic candidates,\u201d said Pete Gough, CSO of Nimble Therapeutics. \u201cWe are excited to further leverage our differentiated platform to accelerate development of optimized candidates against a larger set of novel targets in partnership with Genentech.\u201d\n<\/p>\n

\n\u201cGiven the success of our initial collaboration, we look forward to deepening our partnership with Nimble as we work together against a larger number of important and challenging targets across various disease areas,\u201d said James Sabry, Global Head of Roche Pharma Partnering.\n<\/p>\n

\nAbout Nimble Therapeutics\n<\/p>\n

\nNimble is a biotechnology company dedicated to delivering on the promise of peptide therapeutics. Leveraging a paradigm-shifting peptide drug discovery and development engine, Nimble combines massively parallel solid-phase synthesis, unrivaled chemical and structural diversity, sophisticated assays, and powerful analytics to discover and develop next generation peptide therapeutics efficiently and intelligently. Nimble has extensively validated its platform to identify highly biologically active compounds for multiple programs, spanning a wide variety of therapeutic target classes. For more information, visit www.nimbletherapeutics.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nNimble Therapeutics, Inc.
\n
Brad Garcia, Ph.D.
\n
Vice President, Corporate Development
\n
info@nimbletherapeutics.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MADISON, Wis.–(BUSINESS WIRE)–Nimble Therapeutics, a biotechnology company leveraging its next-generation peptide discovery platform to identify medicines for challenging-to-drug targets, today announced that the company has expanded its collaboration and executed a license agreement with Genentech, a member of the Roche Group (SIX:RO, ROG; OTCQX: RHHBY), for the discovery of peptide therapies for the treatment of … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52587","6":"format-standard","7":"category-industry"},"yoast_head":"\nNimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MADISON, Wis.–(BUSINESS WIRE)–Nimble Therapeutics, a biotechnology company leveraging its next-generation peptide discovery platform to identify medicines for challenging-to-drug targets, today announced that the company has expanded its collaboration and executed a license agreement with Genentech, a member of the Roche Group (SIX:RO, ROG; OTCQX: RHHBY), for the discovery of peptide therapies for the treatment of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-05T15:03:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230105005173\/en\/827173\/21\/nimble-therapeutics-logo-corporate-vertical.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech\",\"datePublished\":\"2023-01-05T15:03:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\\\/\"},\"wordCount\":384,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005173\\\/en\\\/827173\\\/21\\\/nimble-therapeutics-logo-corporate-vertical.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\\\/\",\"name\":\"Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005173\\\/en\\\/827173\\\/21\\\/nimble-therapeutics-logo-corporate-vertical.jpg\",\"datePublished\":\"2023-01-05T15:03:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005173\\\/en\\\/827173\\\/21\\\/nimble-therapeutics-logo-corporate-vertical.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005173\\\/en\\\/827173\\\/21\\\/nimble-therapeutics-logo-corporate-vertical.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/","og_locale":"en_US","og_type":"article","og_title":"Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech - Pharma Trend","og_description":"MADISON, Wis.–(BUSINESS WIRE)–Nimble Therapeutics, a biotechnology company leveraging its next-generation peptide discovery platform to identify medicines for challenging-to-drug targets, today announced that the company has expanded its collaboration and executed a license agreement with Genentech, a member of the Roche Group (SIX:RO, ROG; OTCQX: RHHBY), for the discovery of peptide therapies for the treatment of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-05T15:03:06+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230105005173\/en\/827173\/21\/nimble-therapeutics-logo-corporate-vertical.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech","datePublished":"2023-01-05T15:03:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/"},"wordCount":384,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230105005173\/en\/827173\/21\/nimble-therapeutics-logo-corporate-vertical.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/","url":"https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/","name":"Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230105005173\/en\/827173\/21\/nimble-therapeutics-logo-corporate-vertical.jpg","datePublished":"2023-01-05T15:03:06+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230105005173\/en\/827173\/21\/nimble-therapeutics-logo-corporate-vertical.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230105005173\/en\/827173\/21\/nimble-therapeutics-logo-corporate-vertical.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/nimble-therapeutics-announces-expansion-of-its-discovery-and-development-partnership-with-genentech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52587"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52587\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}